2S-N-Cbz-Homoserine Cyclohexanamine
CAS58578-43-1
2S-N-Cbz-Homoserine Cyclohexanamine (CAS 58578-43-1, C12H23N.C12H15NO5) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 58578-43-1
- Formula
- C12H23N.C12H15NO5
- Mol. weight
- 434.57 g/mol
Chemical Specifications
Identifiers
| CAS number | 58578-43-1 |
|---|---|
| Product name | 2S-N-Cbz-Homoserine Cyclohexanamine |
| Chinese name | 2S-N-Cbz-高丝氨酸二环己胺盐 |
| Synonyms | 2S-N-Cbz-Homoserine Cyclohexanamine |
| Chinese synonyms | 2S-N-CBZ-高丝氨酸二环己胺盐; N-[苄氧羰基]-L-高丝氨酸(二环己基铵)盐 |
| Molecular formula | C12H23N.C12H15NO5 |
| Molecular weight | 434.57 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of 2S-N-Cbz-Homoserine Cyclohexanamine?
The CAS Registry Number of 2S-N-Cbz-Homoserine Cyclohexanamine is 58578-43-1. 2S-N-Cbz-Homoserine Cyclohexanamine is also known as 2S-N-Cbz-Homoserine Cyclohexanamine.
What is the molecular formula and molecular weight of 2S-N-Cbz-Homoserine Cyclohexanamine?
The molecular formula of 2S-N-Cbz-Homoserine Cyclohexanamine is C12H23N.C12H15NO5, and its molecular weight is 434.57 g/mol.
How can I request a quotation for 2S-N-Cbz-Homoserine Cyclohexanamine?
Send an inquiry for 2S-N-Cbz-Homoserine Cyclohexanamine (CAS 58578-43-1) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for 2S-N-Cbz-Homoserine Cyclohexanamine
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.